David J. Kilduff
Lawyers
Filters
Pharmaceutical company $550 million preferred equity acquisition financing
We advised the preferred equity financing sources on the transaction
Gildan Activewear $1.2 billion notes offering
The investment-grade notes are due 2030 and 2035